Table 2 Summary of clinical outcomes after surgical resection to GKS-treated metastases.

From: Histopathology and surgical outcome of symptomatic treatment-related changes after gamma knife radiosurgery in patients with brain metastases

 

Median follow-up (range)

Median OS (range)

Median PFS (range)

6-months LC

1-year LC

TRC-RN

27.7 (7.6–126.5)

43.7 (34.7–51.8)

NA*

84%

78%

TRC-PD

12.8 (2.3–43.9)

16.0 (5.1–26.9)

NA*

79%

68%

PD–PD

14.1 (3.6–58.8)

15.2 (12.2–18.2)

5.4 (2.7–8.0)

41%

26%

  1. LC Local control, NA Not applicable, OS Overall survival, PFS Progression free survival.
  2. *Median PFS of TRC-RN and TRC-PD were not applicable because less than 50% of patients were confirmed with progressive disease after surgical resection during the follow-up period.
Back to article page